Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M277,415Revenue $M74,331Net Margin (%)21.6Altman Z-Score5.3
Enterprise Value $M265,079EPS $5.7Operating Margin %28.1Piotroski F-Score6
P/E(ttm)18.1Beneish M-Score-2.6Pre-tax Margin (%)28.2Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %4.3Quick Ratio2.1Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %3.5Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow20.9y-y EBITDA Growth Rate %16.9ROA % (ttm)12.1Higher Current Ratio y-yY
Dividend Yield %2.9PEG5.2ROE % (ttm)21.6Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,773ROIC % (ttm)27.1Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJTweedy Browne 2015-03-31 Reduce-0.23%$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 2.09%4,055,962
JNJMichael Price 2015-03-31 Reduce-0.13%$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 28.57%25,000
JNJYacktman Focused Fund 2015-03-31 Reduce-0.11%$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 3.23%3,000,000
JNJDonald Yacktman 2015-03-31 Reduce-0.08%$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 2.08%8,432,672
JNJJames Barrow 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 100.04-2%Add 1.19%15,676,362
JNJJohn Rogers 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 100.04-2%Add 3.95%657,074
JNJJoel Greenblatt 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 100.04-2%Add 5.40%833,196
JNJRichard Pzena 2015-03-31 Reduce-0.01%$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 0.84%1,174,016
JNJKen Fisher 2015-03-31 Add0.01%$98.32 - $106.39
($101.69)
$ 100.04-2%Add 0.31%10,456,816
JNJMario Gabelli 2015-03-31 Reduce$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 1.12%333,155
JNJRuane Cunniff 2015-03-31 Reduce$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 0.01%75,937
JNJFirst Eagle Investment 2015-03-31 Add$98.32 - $106.39
($101.69)
$ 100.04-2%Add 0.67%1,627,823
JNJDodge & Cox 2015-03-31 Reduce$98.32 - $106.39
($101.69)
$ 100.04-2%Reduce 9.61%39,985
JNJJoel Greenblatt 2014-12-31 Add0.66%$96.78 - $109.07
($105.43)
$ 100.04-5%Add 5420.84%790,529
JNJRobert Olstein 2014-12-31 Reduce-0.17%$96.78 - $109.07
($105.37)
$ 100.04-5%Reduce 14.46%71,000
JNJJohn Rogers 2014-12-31 Add0.11%$96.78 - $109.07
($105.37)
$ 100.04-5%Add 17.80%632,132
JNJHOTCHKIS & WILEY 2014-12-31 Sold Out $96.78 - $109.07
($105.37)
$ 100.04-5%Sold Out0
JNJHOTCHKIS & WILEY 2014-09-30 Reduce-0.53%$99.82 - $108.64
($103.64)
$ 100.04-3%Reduce 99.80%2,862
JNJJames Barrow 2014-09-30 Reduce-0.24%$99.82 - $108.64
($103.64)
$ 100.04-3%Reduce 10.05%15,350,650
JNJYacktman Focused Fund 2014-09-30 Reduce-0.21%$99.82 - $108.64
($103.64)
$ 100.04-3%Reduce 6.06%3,100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stoffels PaulusChief Scientific Officer 2015-04-28Sell187,250$100.73-0.59view
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.4-2.21view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-7.75view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-6.79view
CULLEN JAMESDirector 2014-09-10Sell2,446$104.12-3.82view
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-3.99view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.050.09view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.157.5view
COSGROVE STEPHEN JCorporate Controller 2013-08-14Sell17,200$91.399.57view
Ullmann Michael HVP, General Counsel 2013-08-05Sell16,140$93.686.9view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Three Reasons Why Retired Investors Should Put Maximum Focus and Weight On Dividends May 29 2015 
    James Barrow increases his position in Johnson and Johnson May 28 2015 
    11 Reasons to be a Dividend Growth Investor May 27 2015 
    Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
    Johnson & Johnson Drug Pipeline to Help it Deliver Above-Average Growth May 22 2015 
    UBS and JMP Securities Downgrade Achillion Pharmaceuticals Inc.(ACHN) Following Johnson & Johnson (J May 21 2015 
    International Diversification May Be Closer than You Think May 20 2015 
    Dycom Industries (DY) Surpasses Estimates; Achillion Pharma (ACHN) Inks Mega-Deal with Janssen May 20 2015 
    Sector Allocation As It Pertains To Dividend Growth Investing May 19 2015 
    Ken Fisher Adds to His Johnson and Johnson Position May 16 2015 

    More From Other Websites
    Pharmalot.. Pharmalittle.. Good Morning: We're Catching up on ASCO, Bristol-Myers and Lots More!! Jun 01 2015
    June 1 Premarket Briefing: 10 Things You Should Know Jun 01 2015
    Johnson & Johnson And The 9 Other Stocks Baby Boomers Love Most Jun 01 2015
    Billionaire Cliff Asness’ Long Term Holdings May 31 2015
    ASCO '15: J&J Antibody Benefits Patients With Hardest-to-Treat Multiple Myeloma May 30 2015
    J&J multiple myeloma drug offers hope after others stop working -study May 30 2015
    U.S. economy contracts in Q1; dollar hurts corporate profits May 29 2015
    1 Positive, 1 Negative For Johnson & Johnson Stock May 29 2015
    Will Gilead's Hepatitis C Dominance Collapse? May 28 2015
    Which Dividend ETFs Provide Steadiest Income? May 28 2015
    J&J accepts offer from Cardinal Health for Cordis unit May 28 2015
    Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis May 28 2015
    New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood... May 28 2015
    Stocks to Watch: Abercrombie & Fitch, Avago Technologies, J&J May 28 2015
    J&J accepts offer from Cardinal Health for Cordis unit May 28 2015
    J&J accepts offer from Cardinal Health for Cordis unit May 28 2015
    Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis May 28 2015
    FBI Is Investigating Hysterectomy Device Found to Spread Uterine Cancer May 27 2015
    Johnson & Johnson's 3 Most Important Numbers May 27 2015
    FBI probing what J&J knew about uterine surgery device - WSJ May 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK